NCT05560061

An Uneven Terrain Surface to Improve Locomotor Robustness in People With Amputation

University of Nevada, Las Vegas·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Amputation
Drug/Device/Intervention
Gait practice on an uneven terrain surface
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Nevada, Las Vegas
Location
Las Vegas, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2022
End date
Dec 31, 2023
Enrollment
10 participants
Primary outcome

Change in single limb stand time from baseline,Change in balance self-efficacy from baseline

Summary

To attain high levels of mobility, people with lower limb amputation must build both the
 skill and the confidence to rely on their prosthesis in the environments that they will
 encounter in daily life. The purpose of this research is to determine whether practicing
 walking on an uneven terrain surface, specifically designed to present a modest, manageable
 disturbance to walking, can improve balance, locomotor flexibility (i.e. the ability to adapt
 walking to different walking contexts) and balance confidence, to a greater extent than
 walking on level ground alone. This preliminary study aims to determine whether uneven
 terrain walking is feasible and acceptable in the target population, and also to establish
 preliminary efficacy.

ICD-10 classifications
Amputation of limb(s)Traumatic amputation of both feetTraumatic amputation of upper and lower limbs, any combination [any level]Traumatic amputations involving other combinations of body regionsTraumatic amputation of lower leg
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05560061
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05560061 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nevada, Las Vegas and is currently Recruiting. The study focuses on Amputation. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.